Kronisk bronkitt
Sist revidert:
Sist revidert av:Peter D. Jost
Definisjon:
Daglig produktiv hoste i mer enn 3 måneder i 2 påfølgende år. Skyldes inhalasjon av skadestoffer, hyppigst tobakksrøyk, ev. luftforurensning eller yrkesmessig eksponering.
Forekomst:
Symptomet kronisk hoste finnes hos 6-7% i befolkningen (inkl. KOLS).
Symptomer:
Diagnosen stilles på bakgrunn av sykehistorie med vedvarende slimhoste uten annen forklaring.
Funn:
Det finnes ingen typiske kliniske funn ved denne tilstanden.
Diagnostikk:
Utredning med spirometri, rtg. eller CT-thorax, samt orienterende blodprøver, kan være aktuelt for å utelukke andre tilstander med slimhoste.
Behandling:
Unngå inhalasjon av skadestoffer. I de fleste tilfellene betyr det røykeslutt.
- Braman SS. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1 Suppl: 104S-115S. pmid:16428699 PubMed
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Ostructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2018 Report. Available from: http://goldcopd.org goldcopd.org
- Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006 Sep;28(3):523-32. PMID: 16611654.
- Mejza F, Gnatiuc L, Buist AS, et al. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study. Eur Respir J. 2017;50(5):1700621. PMID: 29167298 PubMed
- Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187(3): 228-37. pmid:23204254 PubMed
- Pelkonen MK, Notkola IL, Laatikainen TK, Koskela HO. Twenty-five year trends in prevalence of chronic bronchitis and the trends in relation to smoking. Respir Med 2014; 108: 1633-40. pmid:25195139 PubMed
- Martinez CH, Kim V, Chen Y, et al.. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med 2014; 108(3): 491-9. pmid:24280543 PubMed
- Eduard W, Pearce N, Douwes J. Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest. 2009 Sep;136(3):716-25. PMID: 19318669 PubMed
- Hallberg J, Dominicus A, Eriksson UK, Gerhardsson de Verdier M, Pedersen NL, Dahlback M, et al. Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Respir Crit Care Med. 2008 Mar 1;177(5):486-90. PMID: 18048810 PubMed
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2016. www.goldcopd.org
- Poole P, Chong J, Cates CJ. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Syst. Rev. 2015, Issue 7. Art. No.: CD001287. DOI: 10.1002/14651858.CD001287.pub5. DOI
- Allinson JP, Hardy R, Donaldson GC, et al. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development. Am J Respir Crit Care Med 2016; 193(6): 662-72. pmid:26695373 PubMed
- Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res. 2005;6:98. PMID: 16120227 PubMed
- Ferre A, Fuhrman C, Zureik M, et al. Chronic bronchitis in the general population: influence of age, gender and socio-economic conditions. Respir Med. 2012 Mar;106(3):467-71. PMID: 22197577 PubMed
- Peter D. Jost, spesialist i allmennmedisin, redaktør NEL